Statement on CMS Ruling for Aduhelm Coverage
ACHP responds to the Biden Administration’s announcement of Medicare coverage for Aduhelm.
ACHP responds to the Biden Administration’s announcement of Medicare coverage for Aduhelm.
ACHP responds to the Biden Administration’s announcement of Medicare covering over-the-counter COVID tests.
ACHP’s responds to Medicare’s proposal to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm.
ACHP responds to the Biden Administration requiring private insurers to provide coverage for rapid COVID-19 tests.
ACHP and leading health care stakeholders partner to host value week on key legislative and regulatory value-based health care priorities.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.